Código QR (código de barras bidimensional)

Janus kinase inhibitors – a role for the treatment of cutaneous T-cell lymphomas?

Despite increases in prevalence, many cutaneous T-cell lymphoma (CTCL) patients still lack effective and safe therapies for their disease. The most prevalent subtype, mycosis fungoides is usually managed with skin directed treatments in early stages, while advanced stages are often targeted with sys...

תיאור מלא

שמור ב:
Principais autores: Sarah E. Packer, Patrick M. Brunner
פורמט: Artigo
שפה:Inglês
יצא לאור: Frontiers Media S.A. 2025-08-01
סדרה:Oncology Reviews
נושאים:
CTCL
lymphoma
mycosis fugoides
Sezary syndrome
JAK inhibition
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/or.2025.1482866/full
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים